ES2106809T3 - Agente antifungico, su preparacion y microorganismo para ello. - Google Patents

Agente antifungico, su preparacion y microorganismo para ello.

Info

Publication number
ES2106809T3
ES2106809T3 ES92117183T ES92117183T ES2106809T3 ES 2106809 T3 ES2106809 T3 ES 2106809T3 ES 92117183 T ES92117183 T ES 92117183T ES 92117183 T ES92117183 T ES 92117183T ES 2106809 T3 ES2106809 T3 ES 2106809T3
Authority
ES
Spain
Prior art keywords
microorganism
preparation
antifungal agent
xantofulvin
eupenicillium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117183T
Other languages
English (en)
Inventor
Miyako Masubuchi
Toru Okuda
Hisao Shimada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2106809T3 publication Critical patent/ES2106809T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • C07D311/84Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86Oxygen atoms, e.g. xanthones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/933Penicillium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTA XANTOFULVIN DE LA FORMULA QUE SE OBTIENE A PARTIR DE CULTIVOS DE "EUPENICILLIUM SP." EL COMPUESTO PRESENTA ACTIVIDAD ANTIFUNGAL.
ES92117183T 1991-10-09 1992-10-08 Agente antifungico, su preparacion y microorganismo para ello. Expired - Lifetime ES2106809T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91117164 1991-10-09

Publications (1)

Publication Number Publication Date
ES2106809T3 true ES2106809T3 (es) 1997-11-16

Family

ID=8207248

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117183T Expired - Lifetime ES2106809T3 (es) 1991-10-09 1992-10-08 Agente antifungico, su preparacion y microorganismo para ello.

Country Status (13)

Country Link
US (2) US5229123A (es)
EP (1) EP0537622B1 (es)
JP (1) JPH0791284B2 (es)
CN (1) CN1071952A (es)
AT (1) ATE156126T1 (es)
AU (1) AU656028B2 (es)
CA (1) CA2079309A1 (es)
DE (1) DE69221251T2 (es)
DK (1) DK0537622T3 (es)
ES (1) ES2106809T3 (es)
GR (1) GR3024925T3 (es)
NZ (1) NZ244604A (es)
ZA (1) ZA927606B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743783B1 (en) * 1993-12-01 2004-06-01 Marine Polymer Technologies, Inc. Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine
US5624679A (en) * 1993-12-01 1997-04-29 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers
US5622834A (en) * 1993-12-01 1997-04-22 Marine Polymer Technologies, Inc. Method of isolating poly-β-1-4-N-acetylglucosamine from microalgal culture
US5858350A (en) * 1993-12-01 1999-01-12 Marine Polymer Technologies Methods and compositions for poly-β-1→4-N-acetylglucosamine cell therapy system
US5635493A (en) * 1993-12-01 1997-06-03 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics
US5686115A (en) * 1993-12-01 1997-11-11 Marine Polymer Technologies, Inc. Poly-β-1→4-N-acetylucosamine copolymer composition with collagen
US5846952A (en) * 1993-12-01 1998-12-08 Marine Polymer Technologies, Inc. Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery
US6063911A (en) * 1993-12-01 2000-05-16 Marine Polymer Technologies, Inc. Methods and compositions for treatment of cell proliferative disorders
US5789387A (en) * 1995-08-28 1998-08-04 Shaman Pharmaceitucals, Inc. Methods and compositions for treating fungal infections in mammals
US5824545A (en) 1995-11-01 1998-10-20 Millennium Pharaceuticals, Inc. Identification of eukaryotic growth-related genes and promoter isolation vector and method of use
US5888757A (en) * 1996-05-03 1999-03-30 Millennium Pharmaceuticals, Inc. Cell wall assay
WO2002009756A1 (en) * 2000-07-28 2002-02-07 Sumitomo Pharmaceuticals Company, Limited Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
ATE417050T1 (de) * 2002-01-24 2008-12-15 Dainippon Sumitomo Pharma Co Verbindungen als semaphorininhibitoren
US6917256B2 (en) * 2002-08-20 2005-07-12 Motorola, Inc. Low loss waveguide launch
EP2478922B1 (en) 2007-02-19 2017-02-01 Marine Polymer Technologies, Inc. Hemostatic compositions and therapeutic regimens
NZ703163A (en) 2010-04-15 2016-06-24 Marinepolymer Tech Inc Anti-bacterial applications of poly-n-acetylglucosamine nanofibers
AU2012242479B2 (en) 2011-04-15 2015-04-16 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers
CN107827805B (zh) * 2017-06-05 2021-01-22 海南师范大学 一种红树植物木果楝真菌来源的吲哚二萜类化合物及其制备方法与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873714A (en) * 1971-07-14 1975-03-25 Syntex Inc Xanthone carboxylic acids and derivatives

Also Published As

Publication number Publication date
ATE156126T1 (de) 1997-08-15
GR3024925T3 (en) 1998-01-30
JPH05239050A (ja) 1993-09-17
US5229123A (en) 1993-07-20
DE69221251D1 (de) 1997-09-04
US5292648A (en) 1994-03-08
NZ244604A (en) 1995-07-26
DE69221251T2 (de) 1998-03-19
JPH0791284B2 (ja) 1995-10-04
EP0537622B1 (en) 1997-07-30
EP0537622A1 (en) 1993-04-21
DK0537622T3 (da) 1998-03-09
AU2623192A (en) 1993-04-22
CN1071952A (zh) 1993-05-12
AU656028B2 (en) 1995-01-19
ZA927606B (en) 1993-04-13
CA2079309A1 (en) 1993-04-10

Similar Documents

Publication Publication Date Title
ES2106809T3 (es) Agente antifungico, su preparacion y microorganismo para ello.
NO933947D0 (no) Baerer for en hjerteklaffprotese
MD1315B1 (en) Oxim esters and intermediate compositions, process for preparation thereof, compositions, process for pests control.
PT650476E (pt) Agente vasodilatador periferico que contem derivados n-acilados de 4-amino-piperidina como ingredientes activos
BG62620B1 (bg) Карбоциклични съединения
MD1745B2 (en) 4,5-dimethyl-N-2-propenyl-2-(trimethylsilyl)-3-thiophencarboxamide, fungicidal composition on base thereof and method of plants diseases control
AU674378B2 (en) Use of 2-amino-6-A-propylamino-4,5,6, 7-tetrahydrobenzothiazole (pramipexol) as an anti-depressantdrug
TR26646A (tr) Fluoroalkenil bilesikleri ve bunlarin zararlilari (pest'leri) kovucular olarak kullanimi
PT921812E (pt) Preparacoes de insulina contendo um halogenuro
KR890015742A (ko) 이병치료용 국소 제제
ECSP024400A (es) Derivados de pleuromutilina que tiene actividad antibacteriana
ES2143004T3 (es) Derivados de la milbemicina, su preparacion y uso.
ES2140877T3 (es) Composicion herbicida sinergica y metodo de uso de la misma.
EP1020447A4 (en) PYRAZOLE-BASED COMPOUNDS AND PLANT DISEASE CONTROL AGENT
ES2129591T3 (es) Procedimientos y composiciones pesticidas.
ES2085051T3 (es) Usos de 1,1,1,3,3,3-hexafluoropropano.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
DE69614552D1 (de) MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE
BG105051A (en) Agricultural/horticultural bacterial disease injury-controlling agents
ES2170243T3 (es) Composicion insecticida y parasiticida acuosa, su procedimiento de fabricacion y de utilizacion.
GB2327610B (en) Macrolide compositions
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
KR910000106A (ko) 발모촉진제
YU51198A (sh) 1,4 diaril-2,3-difluor-2-buten insekticidni i akaricidni agensi
MY107846A (en) Insect repellents.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537622

Country of ref document: ES